US 11311574
Methods and compositions for targeted cleavage and recombination
granted A61KA61K2035/124A61K35/12
Quick answer
US patent 11311574 (Methods and compositions for targeted cleavage and recombination) held by Sangamo Therapeutics, Inc. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2035/124, A61K35/12